Amylyx Pharmaceuticals, Inc. (AMLX)
31.62
-0.47
(-1.46%)
USD |
NASDAQ |
Sep 11, 16:00
31.63
+0.01
(+0.03%)
After-Hours: 20:00
Amylyx Pharmaceuticals Price : 31.62 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 32.09 | 33.00 | 31.37 | 31.62 | 1.713M |
| Sep 10, 2026 | 31.81 | 32.57 | 31.44 | 32.09 | 1.777M |
| Sep 09, 2026 | 33.50 | 34.35 | 32.30 | 32.40 | 1.287M |
| Sep 08, 2026 | 33.49 | 34.72 | 33.10 | 33.88 | 1.167M |
| Sep 04, 2026 | 33.38 | 34.24 | 33.38 | 34.10 | 885519.0 |
| Sep 03, 2026 | 34.49 | 35.31 | 33.73 | 33.96 | 1.557M |
| Sep 02, 2026 | 34.00 | 35.48 | 34.00 | 34.49 | 1.938M |
| Sep 01, 2026 | 33.49 | 34.21 | 32.99 | 33.81 | 1.822M |
| Aug 31, 2026 | 34.77 | 35.09 | 32.98 | 33.75 | 2.729M |
| Aug 28, 2026 | 36.78 | 37.68 | 34.48 | 34.74 | 1.362M |
| Aug 27, 2026 | 36.75 | 38.23 | 36.53 | 37.18 | 1.989M |
| Aug 26, 2026 | 37.13 | 37.69 | 35.79 | 37.08 | 2.815M |
| Aug 25, 2026 | 38.50 | 38.88 | 36.84 | 37.46 | 2.147M |
| Aug 24, 2026 | 38.64 | 39.38 | 37.45 | 38.15 | 3.714M |
| Aug 21, 2026 | 39.80 | 41.14 | 38.35 | 38.66 | 4.645M |
| Aug 20, 2026 | 37.49 | 40.44 | 37.37 | 39.66 | 8.541M |
| Aug 19, 2026 | 36.13 | 39.07 | 35.32 | 38.60 | 8.262M |
| Aug 18, 2026 | 29.91 | 35.39 | 28.00 | 35.11 | 23.98M |
| Aug 17, 2026 | 21.96 | 22.47 | 21.28 | 21.43 | 1.267M |
| Aug 14, 2026 | 22.35 | 22.39 | 21.29 | 21.63 | 1.589M |
| Aug 13, 2026 | 23.37 | 23.64 | 22.46 | 22.48 | 839453.0 |
| Aug 12, 2026 | 23.86 | 24.08 | 23.30 | 23.35 | 1.454M |
| Aug 11, 2026 | 22.78 | 23.73 | 22.19 | 23.63 | 833859.0 |
| Aug 10, 2026 | 22.68 | 23.03 | 22.00 | 22.67 | 1.331M |
| Aug 07, 2026 | 24.19 | 24.60 | 22.56 | 22.82 | 2.678M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 27.72 |
| Eli Lilly & Co. | 1115.70 |
| Merck & Co., Inc. | 143.93 |
| EyePoint, Inc. | 4.23 |
| Bristol Myers Squibb Co. | 63.64 |
Price Related Metrics
| Price to Book Value | 14.72 |
| Earnings Yield | -4.53% |
| Market Cap | 3.521B |